@wkissel Avatar @wkissel Wolfgang Kissel

Wolfgang Kissel posts on X about $arwr, $mreo, in the, $immp the most. They currently have [------] followers and [---] posts still getting attention that total [-----] engagements in the last [--] hours.

Engagements: [-----] #

Engagements Line Chart

Mentions: [--] #

Mentions Line Chart

Followers: [------] #

Followers Line Chart

CreatorRank: undefined #

CreatorRank Line Chart

Social Influence

Social category influence stocks finance cryptocurrencies countries technology brands travel destinations currencies celebrities automotive brands social networks

Social topic influence $arwr #42, $mreo, in the, $immp, german, australia, $rare, $immax, $alny, $hims

Top accounts mentioned or mentioned by @ej23ny @geneinvesting @rnaianalyst @biomedicalrx @alc2022 @ashton1nvests @arrowheadpharma @biotech2k1 @feldtinvesting @towiu2 @pharmdca @piratewaffle @topsecretstocks @aamortazavi @tedkaridis @semodough @stephanklingel1 @persimmonti @pawcio2009 @bowtiedbiotech

Top assets mentioned Arrowhead Research Corporation (ARWR) SuperRare (RARE) Alnylam Pharmaceuticals, Inc. (ALNY) Hims & Hers Health, Inc. (HIMS) Ionis Pharmaceuticals, Inc. Common Stock (IONS) Intellia Therapeutics, Inc (NTLA) Spotify Technology (SPOT) Pfizer, Inc. (PFE) Muhdo Hub (DNA) Recursion Pharmaceuticals, Inc. (RXRX) AstraZeneca PLC (AZN) Wave Life Sciences Ltd. Ordinary Shares (WVE) AbbVie Inc (ABBV) Enovix Corporation Common Stock (ENVX) BEAM (BEAM) Novo-Nordisk (NVO) Alphabet Inc Class A (GOOGL) Exscientia Ltd. (EXAI) Smart Layer Network (SLN) Novavax Inc (NVAX) Morgan Stanley (MS) Novartis AG (NVS) Kronos Bio, Inc. (KRON) Twist Bioscience Corporation Common Stock (TWST) GSK plc (GSK) Sarepta Therapeutics, Inc. (SRPT) Palantir Technologies Inc. (PLTR) Evotec SE (EVO) Insmed, Inc. (INSM) ROGin AI (ROG) BridgeBio Pharma, Inc. Common Stock (BBIO) Eli Lilly and Company (LLY) CRISPR Therapeutics AG (CRSP) Prime Medicine, Inc. (PRME) Grab Holdings Limited Class A Ordinary Shares (GRAB)

Top Social Posts

Top posts by engagements in the last [--] hours

"Actually this is a disaster. $akao went bankrupt a few months later their product was listed by @WHO WHO berates 'lack of innovation' when it comes to antibiotic pipeline https://www.fiercebiotech.com/biotech/who-berates-lack-innovation-when-it-comes-to-antibiotic-pipeline https://www.fiercebiotech.com/biotech/who-berates-lack-innovation-when-it-comes-to-antibiotic-pipeline"
X Link 2020-01-21T23:37Z [---] followers, [--] engagements

"@MarkC53916729 $AMGN - Amgen Inc. [----] Q4 - Results - Earnings Call Presentation. https://seekingalpha.com/article/4320344-amgen-inc-2019-q4-results-earnings-call-presentationsource=tweet https://seekingalpha.com/article/4320344-amgen-inc-2019-q4-results-earnings-call-presentationsource=tweet"
X Link 2020-01-30T22:02Z [---] followers, [--] engagements

"Very good food for thought. Finding the next Vertex $arwr $alny $glpg and more https://www.evaluate.com/vantage/articles/analysis/spotlight/finding-next-vertexmkt_tok=eyJpIjoiWkRZMU5HTm1PVGxqWW1RMCIsInQiOiJSclRmNWtaeDQyRXpXODFWVjZSY3VjaEJyZnB1Y0N3a2Z5dk51NGRIREpwdVZTeFZDZVIzS1wvUkhkRk40T0hXK0IzNW9XUXJxZlpENnpcL3N5TlAwdkhVS2tNYWozTWRGWkljOVV5TVExU1V3SkZ6RktJY2d5RDZVZnlTV3FORndVIn0%3D"
X Link 2020-10-21T00:11Z [---] followers, [--] engagements

"$SLN $SLN.L $SLN SILENCE THERAPEUTICS PLC - RECEIVES REMAINING $40 MLN FROM $AZN ASTRAZENECA AS PART OF UPFRONT INVESTMENT FOR ONGOING SIRNA COLLABORATION CC @AAMortazavi $SLN SILENCE THERAPEUTICS PLC - RECEIVES REMAINING $40 MLN FROM $AZN ASTRAZENECA AS PART OF UPFRONT INVESTMENT FOR ONGOING SIRNA COLLABORATION CC @AAMortazavi"
X Link 2021-05-25T06:56Z [---] followers, [--] engagements

"$NVAX - Novavax Inc. [----] Q3 - Results - Earnings Call Presentation https://seekingalpha.com/article/4466631-novavax-inc-2021-q3-results-earnings-call-presentationsource=tweet https://seekingalpha.com/article/4466631-novavax-inc-2021-q3-results-earnings-call-presentationsource=tweet"
X Link 2021-11-07T10:24Z [---] followers, [--] engagements

"@RNAiAnalyst No it is about $DDDD from the UK also as a SPAC on NASDAQ under $LBPS 4D Pharma. They called in the administratiors after they could not deal with the debt to Oxford Finance. They are active in the microbiome sector with good combination results with #Keytruda . Sad story"
X Link 2022-08-28T08:24Z [---] followers, [--] engagements

"Free Speech without rules is no Free Speech. @elonmusk Antisemitism is not a "diverse viewpoint" that can be tolerated Antisemitism is not a "diverse viewpoint" that can be tolerated"
X Link 2022-11-04T06:00Z [---] followers, [--] engagements

"Thanks. Great analysis of the field. #metagenomi $IONS $NTLA $ARWR $ALNY $WVE $PRQR $IONS widens its modality horizons (blog): https://t.co/cs5zqQrHfF #metagenomi $NTLA $ARWR $ALNY $WVE $PRQR $IONS widens its modality horizons (blog): https://t.co/cs5zqQrHfF #metagenomi $NTLA $ARWR $ALNY $WVE $PRQR"
X Link 2022-11-14T22:52Z [---] followers, [--] engagements

"$TWIST Looking forward to listening to your presentation at #JPM23 tomorrow. The economic impact of #syntheticbiology is growing in its importance with the global market size increasing from US$9.5 billion in [----] to an estimated $33.2 billion by [----] @EmilyLeproust @FionaRMischel @SynBioBeta #synbio @biocompare https://t.co/nXqIwi1YkB The economic impact of #syntheticbiology is growing in its importance with the global market size increasing from US$9.5 billion in [----] to an estimated $33.2 billion by [----] @EmilyLeproust @FionaRMischel @SynBioBeta #synbio @biocompare https://t.co/nXqIwi1YkB"
X Link 2023-01-09T02:25Z [---] followers, [---] engagements

"@paulxmccarthy @researchremora Is there also one for Germany and Australia/"
X Link 2023-01-09T03:30Z [---] followers, [---] engagements

"Fully agree with points [--] and [--] re $ARWR. So many shots on goal but not scored yet. That's worrisome. [--] regulatory success and $ARWR goes to the moon. $ARWR - Arrowhead Pharmaceuticals Requires Caution https://seekingalpha.com/article/4581284-arrowhead-pharmaceuticals-requires-cautionsource=tweet https://seekingalpha.com/article/4581284-arrowhead-pharmaceuticals-requires-cautionsource=tweet"
X Link 2023-02-23T22:59Z [---] followers, [----] engagements

"@biosleuth Interesting edge computing chip company Brainchip $BRCHF $BRN.ax"
X Link 2023-03-05T20:01Z [---] followers, [---] engagements

"$GLYC Having a closer look $ABBV"
X Link 2023-03-06T03:50Z [---] followers, [---] engagements

"Another great article on #RNAi . Thanks. $ARWR $ALNY $PRQR RNAi also conquers the CNS (blog) https://t.co/3IxQxIzkgW $ALNY $ARWR $IONS $PRQR $WVE RNAi also conquers the CNS (blog) https://t.co/3IxQxIzkgW $ALNY $ARWR $IONS $PRQR $WVE"
X Link 2023-04-26T23:57Z [---] followers, [----] engagements

"@dhovekamp42 @RNAiAnalyst $AFMD Good when one has a basic understanding of German labour law. People have notice periods and consultations with employee representatives. So yes @dhovekamp42 is right. The restructuring process might have started [--] months ago. Seems Adi Hoess is a responsible manager"
X Link 2023-05-24T09:47Z [---] followers, [--] engagements

"Germany retreats from plans to implement $PLTR software for the police across the country . Major concerns about data safety. Bund rckt von Software Palantir ab"
X Link 2023-06-30T05:29Z [---] followers, [---] engagements

"#Australia on second place of mortgage default risk in OECD (IMF). What an achievement. IMF ranks Canada having highest mortgage default risk in the OECD. Not only more & more Canadians can't afford a house but more & more Canadians won't be able to afford to keep their house. Yet the Liberals Bank of Canada acting like it's business as usual. #cdnpoli #cdnecon https://t.co/MFI6G1CarG IMF ranks Canada having highest mortgage default risk in the OECD. Not only more & more Canadians can't afford a house but more & more Canadians won't be able to afford to keep their house. Yet the Liberals Bank"
X Link 2023-07-01T22:12Z [---] followers, [---] engagements

"@Stock_Bonvivant @die_sdk Evotec $EVO"
X Link 2023-07-10T11:06Z [---] followers, [---] engagements

"@RNAiAnalyst BP loves $ALNY but not $ARWR. Why ALNY has products on the market ARWR has not. Just that simple"
X Link 2023-07-25T14:20Z [---] followers, [---] engagements

"@BioBoyScout @TOWiU2 @sonichedgefund @ArrowheadPharma @MorganStanley One other thing why $ALNY is quicker than $ARWR is focus. Smaller pipeline can be a good thing if it is an expression of focus. Believe thats the case with $ALNY"
X Link 2023-07-27T22:11Z [---] followers, [---] engagements

"@Biotech2k1 You know that for $ARWR there is no cheque high enough that shareholders would accept a buyout (quote from CEO)"
X Link 2023-08-15T22:10Z [---] followers, [---] engagements

"@BertrandBio Interestingly Humira one of the highest grossing drugs is not on the list. Reason: it has already [--] competitors. No negotiation needed. $ABBV"
X Link 2023-08-29T11:50Z [---] followers, [--] engagements

"@rlilburne @WilkieMP This is what surprises me. The AG is more than a year in charge. No effort in dropping these charges no effort to free Assange. I am wondering what @MarkDreyfusKCMP is afraid of. It seems a lot https://michaelwest.com.au/spies-like-us-how-natsec-and-attorneys-g-meddle-with-justice-whistleblower-david-mcbride/ https://michaelwest.com.au/spies-like-us-how-natsec-and-attorneys-g-meddle-with-justice-whistleblower-david-mcbride/"
X Link 2023-09-05T06:49Z [---] followers, [--] engagements

"@RNAiAnalyst Thanks. That really is lazy journalism. The report sounds as if there is only [--] vaccine in Germany. $NVAX $BNTX"
X Link 2023-09-06T11:39Z [---] followers, [---] engagements

"@BayAreaBiotechI @TedKaridis @Marty72172937 How did $MREO give it away They own the EU/UK market and they get royalties and milestone payments from $RARE as well"
X Link 2023-09-08T00:12Z [---] followers, [---] engagements

"@Brian_Stoffel_ Will apply this to $SPOT. Then let's see. Excellent thread and lots to learn from. Thanks"
X Link 2023-09-12T00:36Z [---] followers, [---] engagements

"@Brian_Stoffel_ Here are my $SPOT calculations based on published numbers. Gross margin: 25.2% SG&A: 69% Depreciation expense: 5.3% Interest expense: negative (if formula applied 8.7%) Capital expenditure: negative (if formula applied 1.4%) Does this make $SPOT a good investment or not"
X Link 2023-09-12T04:48Z [---] followers, [--] engagements

"@RNAiAnalyst $ARWR listened to the Baird presentation too and Morgan Stanley. Quite impressive what was said and how it was presented (disclaimer: I'm quite critical about @ArrowheadPharma 's communication). But this was really good. The first NDA to be filed in [----] and in market 2025"
X Link 2023-09-15T04:23Z [---] followers, [---] engagements

"Impressive presentation of $ENVX at Morgan Stanley 11th Annual Laguna Conference. It's worth to listen"
X Link 2023-09-15T05:32Z [---] followers, [---] engagements

"$VSTM #KRAS H.C. Wainwright conference . What's not to like other than the current SP Impressive pipeline from a product. https://investor.verastem.com/events/event-details/hc-wainwright-25th-annual-global-investment-conference https://investor.verastem.com/events/event-details/hc-wainwright-25th-annual-global-investment-conference"
X Link 2023-09-15T06:00Z [---] followers, [---] engagements

"@pt117cool [--] Sept [--] -today $ARWR very volatile but best increase in share price from with a high at $90. $6.05-$26.20 363.8% $ALNY 2nd best from $64.80 - $170.70 173.5% $IONS flat from ca $38.6 -$42.9 23.3% So $ARWR is it Data from Yahoo"
X Link 2023-09-28T06:41Z [---] followers, [---] engagements

"Im going to @GeneInvestings upcoming Space. Will you join too"
X Link 2023-09-30T03:13Z [---] followers, [---] engagements

"@RNAiAnalyst Please not $AVRO"
X Link 2023-10-05T20:02Z [---] followers, [---] engagements

"@GeneInvesting @DisruptorStocks @drrichjlaw All gaps are closed"
X Link 2023-10-09T05:38Z [---] followers, [--] engagements

"@Pharmdca @semodough Learned from @ej23ny that $XFOR 's balance sheet is toxic. Huge amount of warrants and big risk of dilution. Have on my radar but staying away until the situation becomes clearer"
X Link 2023-10-19T02:03Z [---] followers, [---] engagements

"@s6m6w6 @ej23ny Too little volume $MREO and too early. If only half of the possible potential and calculations are realistic then the SP has to consolidate way above $3 before serious buyout talks make sense and to justify a decent premium from there"
X Link 2023-10-27T19:20Z [---] followers, [---] engagements

"@Gabriel42869026 @TedKaridis $MREO Best would be partnership with high upfront. This would increase SP significantly. Then the partner buys out when convinced about development. (Learning from $TRIL). Such a scenario could apply to $NVS for #tigit. Setru and Alvelestat could be used to finance a great deal"
X Link 2023-10-28T03:47Z [---] followers, [---] engagements

"@DanTheInvestah @dividendology $POAHY $ABBV"
X Link 2023-11-19T21:07Z [---] followers, [--] engagements

"@DanTheInvestah @dividendology This is the Porsche family holding not the Porsche company. Has a lot of control on Porsche car company and all Volkswagen brands. They call the shots and can change the share classes if the families (Porsche and Piech) think it's in their interest. Until then the dividend"
X Link 2023-11-19T22:56Z [---] followers, [--] engagements

"$SPOT - Spotify: Optimism Is Returning"
X Link 2023-12-04T23:35Z [---] followers, [--] engagements

"$RARE $MREO #OI the competition is not sleeping. $NXTC still pre-clinical but moving forward fast. Same target patients but also talks to NASA (bone loss of astronauts) and military (wound healing). Interesting talk (starts at 11:00 min)"
X Link 2023-12-05T01:02Z [---] followers, [---] engagements

"@ej23ny As mentioned still pre-clinical but one never knows. I would never underestimate a competitor. sometimes things can happen very quick. $MREO $RARE $NXTC"
X Link 2023-12-05T03:47Z [---] followers, [---] engagements

"$ARWR Growing optimism"
X Link 2023-12-07T20:07Z [---] followers, [---] engagements

"Very interesting Felix Zulauf on markets and geopolitics"
X Link 2023-12-10T23:03Z [---] followers, [---] engagements

"@TOWiU2 @leilei_wuu This might be done deliberately. $AFMD . There seems to be a concerted action under way to oust Adi Hoess. He had his chances but chose not to listen. Now they are after him. No matter what the data say. Sad"
X Link 2023-12-13T08:55Z [---] followers, [---] engagements

"@GeneInvesting $SPOT"
X Link 2023-12-14T19:40Z [---] followers, [--] engagements

"@Pharmdca $PFE fits the Dogs of the Dow strategy"
X Link 2023-12-14T23:52Z [---] followers, [---] engagements

"@PredatorDiaries @RNAiAnalyst Exactly $PFE management are no risk takers. Rather than building for the future they go for secure revenue. Ensures their bonuses. Keep in mind they are employees not entrepreneurs. Jeff Bezos would never have built Amazon with that attitude"
X Link 2023-12-15T07:40Z [---] followers, [---] engagements

"Wenn man mal etwas ber Lftung und Covid wissen will. Hier stehts"
X Link 2023-12-20T20:08Z [---] followers, [--] engagements

"@StephanKlingel1 @Pharmdca @PharmDabbler @Phoenix3million @ej23ny @semodough @UShouldBuyThis @ramanveena Happy Holidays to all $MREO disciples and a great BO year"
X Link 2023-12-24T07:58Z [---] followers, [---] engagements

"@Apt_Learner @leadlagreport Thats me 100%. Ask my wife"
X Link 2024-01-05T21:52Z [---] followers, [--] engagements

"@leadlagreport The Alaska Airlines missing piece was found in a backyard. And a still functioning iPhone that fell from the plane was also found"
X Link 2024-01-08T11:07Z [---] followers, [---] engagements

"$PHRRF (L) $PHRRF - Assigned FDA approval goal date of April [--] [----] Had no idea. Not followed them in longtime $PHRRF - Assigned FDA approval goal date of April [--] [----] Had no idea. Not followed them in longtime"
X Link 2024-01-10T19:42Z [---] followers, [---] engagements

"@TedKaridis @wsenti @BHunter3663 $MREO My thesis was always based on Alvelestat. The potential for N-elastase inhibitors in #COPD is almost unlimited and thats outside #AATD. With the growth in COPD patients Alvelestat has blockbuster potential. If I were them I would invest a little to get a foot into COPD. 1"
X Link 2024-01-31T05:44Z [---] followers, 15.3K engagements

"@TedKaridis @wsenti @BHunter3663 A clever CEO could buy $MREO and although its a conglomerate of projects exploit the company project by project by a team of young managers. This could be the most real life management development project ever. Any $MREO project in the right hands could be really big in BP. 2/"
X Link 2024-01-31T05:45Z [---] followers, [----] engagements

"In the near future India will be overwhelmed with a #COPD epidemic. India needs an operation warp speed for #COPD or their healthcare system will collapse. Delhi fog: Poor visibility disrupts life and travel in Indian capital https://t.co/QoOfQkX4rk Delhi fog: Poor visibility disrupts life and travel in Indian capital https://t.co/QoOfQkX4rk"
X Link 2024-01-31T08:01Z [---] followers, [---] engagements

"Eric Schmidt is excited about $RARE and therefore $MREO . Full interview start at about min. 14:30. Eric Schnidt the analyst to watch when it comes to cell therapy. He now likes TCRs like $imcr thinks $blue could be in death spiral. $rare (-- $mreo) as top pick believes setrusumab underappreciated. Eric Schnidt the analyst to watch when it comes to cell therapy. He now likes TCRs like $imcr thinks $blue could be in death spiral. $rare (-- $mreo) as top pick believes setrusumab underappreciated"
X Link 2024-02-01T08:00Z [---] followers, [----] engagements

"@roccafella86 @jonathanjaeger @mdpmartymdp @PersimmonTI $MREO Data from $RARE about Setrusumab (Orbit studies) and their own data about Alvelestat (Astraeus Atalant a studies) and Etiligimab (Activate and EON studies) to name a few"
X Link 2024-02-04T08:14Z [---] followers, [---] engagements

"@BeerBubbelah @Cryptos_Tales They usually answer quite quickly and Lee Roth is actually doing a good job. $MREO. you can follow him on LinkedIn and ask questions"
X Link 2024-02-21T02:57Z [---] followers, [---] engagements

"Nice mention of $MREO #AATD https://seekingalpha.com/article/4678322-newer-treatments-in-alpha-1-antitrypsin-deficiency-2-5-billionyear-market-size-by-2032 https://seekingalpha.com/article/4678322-newer-treatments-in-alpha-1-antitrypsin-deficiency-2-5-billionyear-market-size-by-2032"
X Link 2024-03-14T21:40Z [---] followers, [----] engagements

"$AFMD Affimed Seagen soldiers in long SWOG for Hodgkin lymphoma drug https://t.co/eoRnIbpjaa #biotech #pharma @affimed @SeagenGlobal Affimed Seagen soldiers in long SWOG for Hodgkin lymphoma drug https://t.co/eoRnIbpjaa #biotech #pharma @affimed @SeagenGlobal"
X Link 2024-03-26T03:57Z [---] followers, [----] engagements

"Good thread on $ARWR (L) $ARWR Ill take the opposite and do not care there was no IR call today. Let the data do the talking I also get frustrations when it seems leadership is sleeping from my experience when that is assumed Ive been wrong 💯 of the time. The flashy / PR happy is more concerning 1/2 $ARWR Ill take the opposite and do not care there was no IR call today. Let the data do the talking I also get frustrations when it seems leadership is sleeping from my experience when that is assumed Ive been wrong 💯 of the time. The flashy / PR happy is more concerning 1/2"
X Link 2024-04-09T03:06Z [---] followers, [----] engagements

"$MREO A sober view on valuation. But is this really the point https://seekingalpha.com/article/4683033-mereo-biopharma-stock-pipeline-promise-versus-valuation-market-realities https://seekingalpha.com/article/4683033-mereo-biopharma-stock-pipeline-promise-versus-valuation-market-realities"
X Link 2024-04-10T08:31Z [---] followers, [---] engagements

"Another kick in the guts for $ARWR Dosing convenience doesn't matter Well. $IONS - Wolfe upgrades Ionis to outperform cites upcoming catalysts https://seekingalpha.com/news/4088643-wolfe-upgrades-ionis-to-outperform-cites-upcoming-catalystssource=tweet https://seekingalpha.com/news/4088643-wolfe-upgrades-ionis-to-outperform-cites-upcoming-catalystssource=tweet"
X Link 2024-04-10T23:44Z [---] followers, [---] engagements

"@bio_2024 Yes you are right biotech is interest rate sensitive. However - The government did not hike interest rates that was the FED (independent) - There are people who can show you similar charts showing that Obama vs Trump won hands down in stock market development. 1/"
X Link 2024-04-22T04:38Z [---] followers, [--] engagements

"@GeneInvesting Thats what I mean. The @Ginkgo $DNA disaster is not the market. That would be a cheap excuse. Let him explain what else is"
X Link 2024-04-27T22:19Z [---] followers, [---] engagements

"@GeneInvesting @Ginkgo When a company like @Ginkgo $DNA looses 90% of value since IPO then it is not the market and not the [--] year yield. It is management like the Jason Kellys who over promise and under delivers. We shareholders should not look for excuses. Please invite him and he should explain"
X Link 2024-04-28T05:12Z [---] followers, [---] engagements

"@revkuk179937 @jfais20 No $MREO owns the drug and has licensed it to $RARE in [----] and retains the rights for EU/EEA and the UK. $MREO has acquired Setrusumab from $NVS in 2015"
X Link 2024-04-29T04:27Z [---] followers, [---] engagements

"@OddDiligence Dont forget the 4:1 split. $GME"
X Link 2024-05-14T22:07Z [---] followers, [---] engagements

"@BeerBubbelah @AgAg255993 @PickingMyOwn I for my part couldnt. IR wanted help but my broker refused to follow up on the proxy documents. So I couldnt. Maybe happened to others too"
X Link 2024-05-23T22:46Z [---] followers, [---] engagements

"Thank you very much for your insights. $EXAI (L) @Biotech2k1 @exscientiaAI @wkissel LSD1 is actually involved in different signalling pathways in different cancers; https://t.co/efm1l6TaqU @Biotech2k1 @exscientiaAI @wkissel LSD1 is actually involved in different signalling pathways in different cancers; https://t.co/efm1l6TaqU"
X Link 2024-06-05T21:11Z [---] followers, [---] engagements

"$EXAI (L) Vastly undervalued Then show us the data and that you are able to clean your house. https://seekingalpha.com/article/4698468-exscientia-too-much-pessimism https://seekingalpha.com/article/4698468-exscientia-too-much-pessimism"
X Link 2024-06-11T09:16Z [---] followers, [---] engagements

"So $RARE is raising capital and is-10% down pre market. Hope that $MREO does not get dragged down"
X Link 2024-06-13T09:39Z [---] followers, [----] engagements

"@BIOSF3AR @ej23ny $MREO (L) The gap comes from the difference in the pipeline. $INSM (NP) has an approved product with big growth potential and anticipated revenue of $900M in [----]. They have [--] P3 and [--] P2 products and several P1 and pre-clinical projects. Not apples to apples"
X Link 2024-07-06T05:11Z [---] followers, [---] engagements

"$ENVX (L) The TAM can be huge. Execution and delivery is everything. https://seekingalpha.com/article/4702668-enovix-big-solution-for-growing-problem-phone-needs-better-battery https://seekingalpha.com/article/4702668-enovix-big-solution-for-growing-problem-phone-needs-better-battery"
X Link 2024-07-06T06:14Z [---] followers, [---] engagements

"@Retirefund @CrisprGlenn Good idea. But it only makes sense under the leadership of @twst (L) and by removing $dna (L) management mostly @jrkelly"
X Link 2024-07-10T03:40Z [---] followers, [---] engagements

"@pawcio2009 @LTbioinvestor The $xbi from [--] is not the one from [--]. If it would be a company in [--] it was $DNA in [--] its $ABBV"
X Link 2024-07-16T22:23Z [---] followers, [---] engagements

"$IMMP $IMM.ax @Immutep announces successful meeting with @US_FDA on Phase III trial design to evaluate efti in combination with KEYTRUDA and standard chemotherapy in first-line non-small cell lung cancer. Read here: https://t.co/cXnOq3w7bk #LAG3 #biotechnology $IMM $IMMP https://t.co/1wiKUOzpZ4 @Immutep announces successful meeting with @US_FDA on Phase III trial design to evaluate efti in combination with KEYTRUDA and standard chemotherapy in first-line non-small cell lung cancer. Read here: https://t.co/cXnOq3w7bk #LAG3 #biotechnology $IMM $IMMP https://t.co/1wiKUOzpZ4"
X Link 2024-07-22T00:56Z [---] followers, [---] engagements

"$ENVX Enovix Corporation $ENVX Q2 [----] EARNINGS CALL SUMMARY https://t.co/zdZefI9pZ0 Enovix Corporation $ENVX Q2 [----] EARNINGS CALL SUMMARY https://t.co/zdZefI9pZ0"
X Link 2024-08-01T02:20Z [---] followers, [---] engagements

"Now send those $ARWR guys as interns to $ALNY to learn how this is done. What a difference. In Jan [----] we launched our Alnylam P5x25 strategy for building a top [--] biotech by end of [----] On Friday we achieved that milestone AMGN VRTX REGN GILD ALNY Congrats to the amazing @Alnylam team https://t.co/pCmobOXMEY In Jan [----] we launched our Alnylam P5x25 strategy for building a top [--] biotech by end of [----] On Friday we achieved that milestone AMGN VRTX REGN GILD ALNY Congrats to the amazing @Alnylam team https://t.co/pCmobOXMEY"
X Link 2024-08-03T21:56Z [---] followers, [----] engagements

"@Orangeman1992 Every retail investor who sells today will lose money big time"
X Link 2024-08-05T05:22Z [---] followers, [--] engagements

"@CashLorenShow Watch VEEP and then you know what a VP can do. It's funny but very realistic"
X Link 2024-08-23T05:03Z [---] followers, [---] engagements

"$ENVX Thanks for the excellent thread @EarningsNugget . Yea the potential is there. Now lets observe the execution. Not too much concerned about the cash burn. They need to spend money to get the manufacturing running. 1/ 🔋 Let's talk about Enovix $ENVX the battery company that's trying to solve your phone's biggest problem: battery life. A thread on why this could be huge. or not. 🧵 https://t.co/2v6j4bVl1J 1/ 🔋 Let's talk about Enovix $ENVX the battery company that's trying to solve your phone's biggest problem: battery life. A thread on why this could be huge. or not. 🧵"
X Link 2024-08-24T01:33Z [---] followers, [----] engagements

"$MREO 2/ $MREO Mereo 2nd MOA drugs (forgotten drug $0 value) 2) Alvelestat similar MOA to $INSM $13.13Bn MC brensocatib Baird report on $MREO Alvelestat has similar MOA to brensocatib also Mereo completed phase [--] Bronchiectasis study at very low dose $XBI $BMY $NVS $AZN $NOV https://t.co/D1FUQfvySy 2/ $MREO Mereo 2nd MOA drugs (forgotten drug $0 value) 2) Alvelestat similar MOA to $INSM $13.13Bn MC brensocatib Baird report on $MREO Alvelestat has similar MOA to brensocatib also Mereo completed phase [--] Bronchiectasis study at very low dose $XBI $BMY $NVS $AZN $NOV https://t.co/D1FUQfvySy"
X Link 2024-08-27T20:40Z [---] followers, [----] engagements

"@DalrympleWill @muk22 @the_hindu 17th September in Australia I saw your book in our bookstore already last week"
X Link 2024-09-06T12:19Z [---] followers, [--] engagements

"$ENVX podcast summary from @EarningsNugget . Thanks. $ENVX 1/ Just listened to a newly released podcast with Raj Talluri CEO of Enovix. They're doing some cool stuff with battery tech that could be a game-changer for our devices. 🔋📱 #BatteryTech Here's a thread of the main takeaways: 🧵THREAD https://t.co/5K7SxYX3UF $ENVX 1/ Just listened to a newly released podcast with Raj Talluri CEO of Enovix. They're doing some cool stuff with battery tech that could be a game-changer for our devices. 🔋📱 #BatteryTech Here's a thread of the main takeaways: 🧵THREAD https://t.co/5K7SxYX3UF"
X Link 2024-09-19T22:14Z [---] followers, [---] engagements

"@jdubois1234 @8thKingofRome @ny1972_47 @affimed @lelandspharmd $AFMD Have voted No. Cashing in before performance delivered. Btw just saw the base salary for the new $NKE CEO. He gets $1.5M . And this is for $120B company. I know its not apples to apples but still"
X Link 2024-09-20T20:56Z [---] followers, [---] engagements

"@MLBULL1 @AlanCastle15 @jonathanjaeger @stefansladecek @ej23ny $MREO Companies rarely use their cash to acquire another company. They use stock or debt. In case of debt they calculate the expected return/revenue to pay it off. $RARE can easily finance a BO of Setru for $1B. The rest of $MREO goes to a BP for $2B. That would make sense"
X Link 2024-09-22T03:58Z [---] followers, [----] engagements

"@MLBULL1 @AlanCastle15 @jonathanjaeger @stefansladecek @ej23ny $MREO I know but when it is a cash deal its cash through debt and not from cash in the bank. Thats why $RARE could buy Setru (for $1B IMHO)"
X Link 2024-09-22T10:52Z [---] followers, [----] engagements

"@dayalamit @Biohazard3737 @sharkbiotech $ARWR The market wants the CEO/management out. No matter what data they publish. CA has lost all trust beyond repair and SP goes down until hes out. @ArrowheadPharma is a great company with huge potential. But market will kick management out. Happened with bigger companies"
X Link 2024-09-23T20:46Z [---] followers, [---] engagements

"@sonichedgefund $ARWR The market wants the CEO/management out. No matter what data they publish. CA has lost all trust beyond repair and SP goes down until hes out. @ArrowheadPharma is a great company with huge potential. But market will kick management out. Happened with bigger companies"
X Link 2024-09-23T20:46Z [---] followers, [----] engagements

"$ARWR [--] in [--] already achieved in [--]. Let the bonuses come in. @sonichedgefund $ARWR The market wants the CEO/management out. No matter what data they publish. CA has lost all trust beyond repair and SP goes down until hes out. @ArrowheadPharma is a great company with huge potential. But market will kick management out. Happened with bigger companies. @sonichedgefund $ARWR The market wants the CEO/management out. No matter what data they publish. CA has lost all trust beyond repair and SP goes down until hes out. @ArrowheadPharma is a great company with huge potential. But market will kick"
X Link 2024-09-23T20:56Z [---] followers, [---] engagements

"@BK7959925597715 @BiomedicalRX @Biotech2k1 @yaireinhorn $MGX Some people say that there might be a problem with $BEAM IP . In their presentation they do not comment on the strength of their IP. In comparison $PRQR does"
X Link 2024-09-24T05:29Z [---] followers, [---] engagements

"@yaireinhorn @Stifel @WaveLifeSci @Alnylam @ArrowheadPharma $WVE Where would you put $ARWR s INHBE program Similar Superior"
X Link 2024-09-29T22:06Z [---] followers, [---] engagements

"@BertrandBio $RHHBY $ROG [--] years after the Boehringer Mannheim ($11B) acquisition the original strategy of creating an integrated Pharma/Diagnostic health company might come true. Took quite long. And thanks for the comprehensive summary"
X Link 2024-09-30T09:16Z [---] followers, [--] engagements

"$ARWR Impressive presentation about siRNA in CNS. If only one the programs work it would be epic. But it's $ARWR so it might take a while until the market recognizes the breakthrough potential of this revolutionary approach. Join @ArrowheadPharma $ARWR for Part V of its Summer Series of R&D webinars on Mon Oct. [--] at 4:30pm ET with Jose Soria MD. Arrowhead management will provide updates on its CNS programs including two new candidates. Register: https://t.co/jt7mEzv9XY https://t.co/WrZKQxslWi Join @ArrowheadPharma $ARWR for Part V of its Summer Series of R&D webinars on Mon Oct. [--] at 4:30pm"
X Link 2024-10-08T06:57Z [---] followers, [----] engagements

"@RNAiAnalyst You are right in this specific case of $ALNY . Same might be true for $ARWR and Roche. My comment is more in general for the Pharma industry. Happens in other industries too. The man from DECCA the most famous one"
X Link 2024-10-15T07:50Z [---] followers, [---] engagements

"@BiomedicalRX $ARWR ytd -30%. Biotech moves quickly depending from where you look. My target price is in the range of when $ARWR is a Big Biotech"
X Link 2024-10-19T05:09Z [---] followers, [---] engagements

"Excellent explanation of $PLTR and what they are doing. Thanks. 🔮Palantir explained in the most basic way: People still ask What does Palantir do. Many are disingenuous but some honestly still dont understand it. Heres how I view Palantir at its most basic form: Lets start off with the name of the company Palantir. The name https://t.co/tPeRRqKy2m 🔮Palantir explained in the most basic way: People still ask What does Palantir do. Many are disingenuous but some honestly still dont understand it. Heres how I view Palantir at its most basic form: Lets start off with the name of the company"
X Link 2024-10-22T06:36Z [---] followers, [---] engagements

"@czorbs @BiomedicalRX $ARWR Mistrust in managements execution. Overpromising and under delivering"
X Link 2024-10-22T21:05Z [---] followers, [---] engagements

"Excellent $ROG $RHHBY update. Thanks. $ROG $RHHBY Roches strong sales growth of 9% (CER) continues in the third quarter of 2024; Group sales increase 6% in the first nine months top-line beat guidance confirmed seemingly no big scoop (no SKY-01) https://t.co/FbTtSCEfU9 $ROG $RHHBY Roches strong sales growth of 9% (CER) continues in the third quarter of 2024; Group sales increase 6% in the first nine months top-line beat guidance confirmed seemingly no big scoop (no SKY-01) https://t.co/FbTtSCEfU9"
X Link 2024-10-23T07:18Z [---] followers, [---] engagements

"@Quartr_App @SvnCapital @AbcpokerBI @Lou_Mannheim @Caaarli552 @aktiechaffisen @Quality_stocksA @Th__Nielsen @NordnetAxel @HerrKamrer Wrong ticker $EVO is Evotec. Evolution is $EVVTY "
X Link 2024-10-24T08:06Z [---] followers, [----] engagements

"@StephanKlingel1 @mtheory11bio @semodough @ej23ny Thanks for the great find on setru $MREO $RARE. It sounds great to hear from a neutral doctor on the hopes they have for a therapy in OI. And a competitor is years away"
X Link 2024-10-24T09:19Z [---] followers, [---] engagements

"Serious question to $LPTX experts. LT shareholder with $22 entry. Averaging down or holding until results of DKN-01 and fl-501 results. Not looking for financial advice just honest views. Thanks"
X Link 2024-10-27T06:19Z [---] followers, [----] engagements

"$LPTX Couldnt agree more. (Chinatown Bangkok)"
X Link 2024-10-31T04:59Z [---] followers, [---] engagements

"@BIOTECHSCANNER How does $AUR management communicate with shareholders when things dont go optimal Thinking of the $ENVX disaster yesterday. T"
X Link 2024-10-31T23:58Z [---] followers, [---] engagements

"Excellent summary of what might be going on at $envx . Thanks. Thats a strong indication theyve got a premium product. But is it manufacturable We were given some confidence on that front as well. COO Ajay indicating yields on agility line are now near 80% which if you recall from a Loop capital note back in fall of [--] thats a https://t.co/Ah8VgwIEEr Thats a strong indication theyve got a premium product. But is it manufacturable We were given some confidence on that front as well. COO Ajay indicating yields on agility line are now near 80% which if you recall from a Loop capital note back in"
X Link 2024-11-03T07:14Z [---] followers, [----] engagements

"$prqr $wve Buoyed by milestone clinical result RNA editing is poised to treat diseases Science AAAS https://t.co/scHjHXmzg4 $wve $prqr Buoyed by milestone clinical result RNA editing is poised to treat diseases Science AAAS https://t.co/scHjHXmzg4 $wve $prqr"
X Link 2024-11-03T07:57Z [---] followers, [---] engagements

"@TOWiU2 What about Alvelestat ($MREO) when approved #COPD"
X Link 2024-11-05T10:59Z [---] followers, [---] engagements

"@TOWiU2 $MREO Currently Alvelestat is tested for #AATD a subset of #COPD. In the USA and Europe there are 100k patients. When approved Alvelestat could be extended to other #COPD patient groups"
X Link 2024-11-05T11:31Z [---] followers, [----] engagements

"Thanks for the good summary $MREO $RARE 1/ A few notes and comments after this weeks $RARE conference call regarding setrusumab that was somewhat previously undisclosed (relevant to $MREO) 1/ A few notes and comments after this weeks $RARE conference call regarding setrusumab that was somewhat previously undisclosed (relevant to $MREO)"
X Link 2024-11-07T06:57Z [---] followers, [----] engagements

"@Biotech2k1 @GeneInvesting Yes you are correct. My fault. It is an expense what many tried to hide in the past"
X Link 2024-11-08T11:36Z [---] followers, [--] engagements

"$ARWR Arrowhead Pharma $ARWR will begin its first phase [--] study in obesity this month. ARO-INHBE is designed to silence the INHBE gene discovered recently in the UK Biobank. Unique among obesity genes it's expressed solely in the liver -- the perfect opportunity for RNAi platforms. https://t.co/rCuk3gaZyV Arrowhead Pharma $ARWR will begin its first phase [--] study in obesity this month. ARO-INHBE is designed to silence the INHBE gene discovered recently in the UK Biobank. Unique among obesity genes it's expressed solely in the liver -- the perfect opportunity for RNAi platforms."
X Link 2024-11-08T13:21Z [---] followers, [---] engagements

"@FifthAce3 @RocketPenguin75 @keeganm5858 Im out of $envx (with a small loss). Raj and his CFO lost all trust with their mess up since ER. Maybe silicon is the future but not with them. Totally untrustworthy"
X Link 2024-11-09T09:21Z [---] followers, [---] engagements

"@PirateWaffle Any idea why the CEO of $kron bought so many shares this year He must know the potential or lack of potential of the company. He also is a seasoned executive/former CEO of $gild"
X Link 2024-11-13T22:11Z [---] followers, [---] engagements

"@PirateWaffle Thank you very much for your detailed reply and insights on $KRON"
X Link 2024-11-13T23:51Z [---] followers, [---] engagements

"@fiddybcent @PirateWaffle In earlier comment I said he might want to take $KRON private. But the compliance thesis might be more accurate. Anyway he puts a lot of money at risk"
X Link 2024-11-14T02:27Z [---] followers, [---] engagements

"$ARWR All cardiologists need to know about Plozasiran from Arrowhead for treating FCS SHTG and Dyslipidemia - just incredible data and results - a diamond in the rough that will transform how patients are treated. Well worth stopping by and learning more. #AHA24 https://t.co/aVmXBUdVER All cardiologists need to know about Plozasiran from Arrowhead for treating FCS SHTG and Dyslipidemia - just incredible data and results - a diamond in the rough that will transform how patients are treated. Well worth stopping by and learning more. #AHA24 https://t.co/aVmXBUdVER"
X Link 2024-11-16T21:02Z [---] followers, [---] engagements

"$ARWR Great study on plozasiran in PALISADE trial presented today #AHA24 and published in @CircAHA https://t.co/jbQoK2luGH Great study on plozasiran in PALISADE trial presented today #AHA24 and published in @CircAHA https://t.co/jbQoK2luGH"
X Link 2024-11-16T21:04Z [---] followers, [---] engagements

"@SridharSalur @BiomedicalRX What edge $ARWR has quarterly dosing no SAE and better efficacy than $IONS"
X Link 2024-11-17T05:42Z [---] followers, [---] engagements

"Great summary on setru $MREO $RARE $RARE Ultragenyx is managing both phase [--] studies of $MREO Setrusumab which qualifies for a PRV. Both P3 trials have been underway since EOY [----]. This drug has Breakthrough Therapy Designation and Rare Pediatric Designation for OI. Both trials are doing exceptionally well as $RARE Ultragenyx is managing both phase [--] studies of $MREO Setrusumab which qualifies for a PRV. Both P3 trials have been underway since EOY [----]. This drug has Breakthrough Therapy Designation and Rare Pediatric Designation for OI. Both trials are doing exceptionally well as"
X Link 2024-11-17T05:45Z [---] followers, [----] engagements

"$PDSB Thanks for the summary. 1/ While us long timers feel sorry about ourselves and our losses this week in $PDSB let's not forget why we invested in it. We are focused on Versamune HPV and phase [--] but let's not forget our IL-12 M9241 aka PDS01ADC. NCI is currently recruiting for [--] trials using our IL-12 https://t.co/G4dXoiJO26 1/ While us long timers feel sorry about ourselves and our losses this week in $PDSB let's not forget why we invested in it. We are focused on Versamune HPV and phase [--] but let's not forget our IL-12 M9241 aka PDS01ADC. NCI is currently recruiting for [--] trials using"
X Link 2024-11-17T21:20Z [---] followers, [----] engagements

"$MREO Alvelestat $AZN @AstraZeneca COPD is responsible for [---] deaths every hour. You can help change this statistic. Early detection and diagnosis paired with timely access to comprehensive care can reduce the burden. This #WorldCOPDDay take a stand against COPD: https://t.co/rg7xWtqBNX #SpeakUpforCOPD https://t.co/6v4K1OP9Tq COPD is responsible for [---] deaths every hour. You can help change this statistic. Early detection and diagnosis paired with timely access to comprehensive care can reduce the burden. This #WorldCOPDDay take a stand against COPD: https://t.co/rg7xWtqBNX #SpeakUpforCOPD"
X Link 2024-11-20T09:11Z [---] followers, [----] engagements

"@Radzikowski @mil30557647 Could $AFMD be the inverse $TRIL From $12 to $0.27 (before r/s)"
X Link 2024-11-21T05:36Z [---] followers, [---] engagements

"@GeneInvesting $NTLA I see your point but he has a point too . A revolutionary technology like GE should be applied to diseases/conditions where there is nothing. That could lead to a breakthrough. Physicians will always go for what is established. When there is nothing then they will try"
X Link 2024-11-21T06:30Z [---] followers, [---] engagements

"@GeneInvesting Wait and see when its approved. $NTLA A change in ones dna could be scary for many when there is a proven alternative. Thats why I am saying a revolutionary technology needs to be applied where there is no alternative. That stops the naysayers. Otherwise they never stop"
X Link 2024-11-21T06:54Z [---] followers, [---] engagements

"$LPTX Im long. But if this is all right (and believe it is) why does the market not react with a huge move up What is it that I dont get Just dont get it. BLOCKBUSTER MARKET: Cancer cachexia $LPTX $PFE 🔘50% of cancer patients86% at end-of-life 🔘45% lose 10% body weight 🔘9M patients globally 🔘22% of cancer deaths due to cachexia 🔘Gastric(70%) lung(80%) liver/PDAC (90%) https://t.co/Ep4aqYKLMd BLOCKBUSTER MARKET: Cancer cachexia $LPTX $PFE 🔘50% of cancer patients86% at end-of-life 🔘45% lose 10% body weight 🔘9M patients globally 🔘22% of cancer deaths due to cachexia 🔘Gastric(70%)"
X Link 2024-11-26T04:40Z [---] followers, [----] engagements

"@BiotechXGuru $MREO Why Its a dormant project. The company never advertised for it. Only some people on twitter are referring to it"
X Link 2024-11-26T08:32Z [---] followers, [---] engagements

"$MREO https://seekingalpha.com/article/4740442-mereo-biopharma-setrusumab-chugs-along-with-possible-inflection-points https://seekingalpha.com/article/4740442-mereo-biopharma-setrusumab-chugs-along-with-possible-inflection-points"
X Link 2024-11-26T21:08Z [---] followers, [----] engagements

"$ARWR $AFMD Only serious analysis accepted. Still looking for good mid stage companies if anyone know any. These are companies with some phase [--] data up to starting phase [--]. I got plenty of time to do research tomorrow through next Monday. Still looking for good mid stage companies if anyone know any. These are companies with some phase [--] data up to starting phase [--]. I got plenty of time to do research tomorrow through next Monday"
X Link 2024-11-27T21:11Z [---] followers, [----] engagements

"@alc2022 How does $DUOL compare to $COUR Have tried many courses at $COUR and learned a lot. Not yet tried $DUOL"
X Link 2024-11-28T04:07Z [---] followers, [---] engagements

"@PirateWaffle $KRON Still baffled. How could Bischofsberger miscalculate his company so badly"
X Link 2024-11-28T04:19Z [---] followers, [---] engagements

"@PirateWaffle $KRON Thanks. Looking back for me the beginning of the end was when they bought the SYK assets from $GILD (Bischofsbergers former company). They wanted to become a clinical stage company quickly. They should have stuck to a slower pace with their own research"
X Link 2024-11-28T05:12Z [---] followers, [---] engagements

"@GeneInvesting You could have said the same thing about $TRIL (L) investors. Still can say the same thing about $ARWR (L) and $MREO (L) Investors. Even $AFMD (L). At the end the SP decides who made a good investment"
X Link 2024-11-28T08:55Z [---] followers, [----] engagements

"@GeneInvesting $ARWR was a penny stock and had to go through a 1:10 r/s"
X Link 2024-11-28T19:31Z [---] followers, [---] engagements

"Very good thread on $NTLA. Great details I wasnt aware of. 🧵ATTR-CM will be my alpha as its been severely undervalued by the investment community. So much so that it makes me question my sanity. Look at the [--] main companies (YTD): $PFE: -10.3% ($6b CM rev in 24) $BBIO: -31.9% (best ph.3 data) 🤔 $ALNY: +32.6% (worst drug) $NTLA: https://t.co/Er2PXAagvQ 🧵ATTR-CM will be my alpha as its been severely undervalued by the investment community. So much so that it makes me question my sanity. Look at the [--] main companies (YTD): $PFE: -10.3% ($6b CM rev in 24) $BBIO: -31.9% (best ph.3 data) 🤔"
X Link 2024-11-29T21:47Z [---] followers, [---] engagements

"@GeneInvesting @DarrenEstes @Reg0sce @BiotechAnalysst @ShortsellerST $SGMO shareholder again since [--] months after [--] unsuccessful attempts (small loss though). The picture is brightening. Lets see how this goes. Was a SH of $NTLA at $40. Did not convince me and left at $33. Now closely observing"
X Link 2024-11-30T00:19Z [---] followers, [---] engagements

"$MREO has a small molecule for AATD ready for p3. Way ahead of $NTLA"
X Link 2024-11-30T23:42Z [---] followers, [----] engagements

"Missing $ARWR"
X Link 2024-12-01T23:28Z [---] followers, [----] engagements

"@BiomedicalRX $MGX Good strategy. If a strong partner comes along as it happened with $PRQR and $LLY then they will go up"
X Link 2024-12-02T00:17Z [---] followers, [---] engagements

"@Partimefriend That would be something really big. $ARWR The pre-clinic data are impressive. now let's go into the clinic"
X Link 2024-12-02T03:38Z [---] followers, [---] engagements

"@Partimefriend Again great thesis $ARWR. Where can I find more information about this MoA Haven't found anything on the website. Thanks"
X Link 2024-12-02T04:32Z [---] followers, [---] engagements

"Its you 😉 $ARWR I am sorry $ARWR fans but I did all my due diligence and found it wanting. Top [--] indications are extremely competitive in cholesterol. The rest are partnered or very early stage. Maybe its me but I dont get it. I am sorry $ARWR fans but I did all my due diligence and found it wanting. Top [--] indications are extremely competitive in cholesterol. The rest are partnered or very early stage. Maybe its me but I dont get it"
X Link 2024-12-03T01:59Z [---] followers, [----] engagements

"Or instead of GLP1 drugs to work on the Moa of INHBe and alk7. $ARWR. New drugs that keep muscle tissue will replace the 1st generation of obesity drugs"
X Link 2024-12-03T02:21Z [---] followers, [---] engagements

"$TWST 🎉 Congratulations to all of the authors on this important piece. We strongly support DNA synthesis screening tools and this preprint exemplifies that sentiment. Special congratulations to our very own James Diggans on this work. 🎉 Congratulations to all of the authors on this important piece. We strongly support DNA synthesis screening tools and this preprint exemplifies that sentiment. Special congratulations to our very own James Diggans on this work"
X Link 2024-12-05T04:25Z [---] followers, [---] engagements

"@Globalstats11 If its only [--] invention per country for Germany I would rate the printing press over the automobile"
X Link 2024-12-08T07:23Z [---] followers, [---] engagements

"@alc2022 $TWST because of its leading role in NGS and in its technology in DNA data storage"
X Link 2024-12-17T11:17Z [---] followers, [---] engagements

"@BrianUherek @SenJohnKennedy This was a right decision. Im against the death penalty. And these criminals will now rot in prison where they deserve to be. This is a much tougher penalty"
X Link 2024-12-23T21:14Z [---] followers, [--] engagements

"@BrianUherek @SenJohnKennedy A civil society has always to be better than the culprits. Otherwise it's just revenge. That's what justice is for. To punish the criminals and to help the victims to overcome their loss and grief. The death penalty does not do this"
X Link 2024-12-24T00:06Z [---] followers, [--] engagements

"@auditor112017 @crisprtalk @Singlemalt_18 @US_FDA $ARWR Something must be left for $IONS"
X Link 2024-12-25T03:30Z [---] followers, [---] engagements

"@BowTiedBiotech $LPTX works with their FL-501 on GDF-15. Different to DKK1 not the same. Min. 2:45"
X Link 2024-12-26T00:28Z [---] followers, [---] engagements

"@Pharmdca That would be $ARWR"
X Link 2024-12-27T02:47Z [---] followers, [---] engagements

"This is a helpful reminder for all. There actually are winners in #biotech . Thanks to @pawcio2009 for organising this great competition. Disclaimer: I ended way down the list with my loser bet on $NXTC The winner of the #Biopick2024 contest is $LBPH with 895% gain and a buyout 🏆🍻 2nd place goes to $ARQT with 331% gain 👏 3rd place $ADMA 279% https://t.co/CR2A6Tzgst The winner of the #Biopick2024 contest is $LBPH with 895% gain and a buyout 🏆🍻 2nd place goes to $ARQT with 331% gain 👏 3rd place $ADMA 279% https://t.co/CR2A6Tzgst"
X Link 2025-01-01T03:33Z [---] followers, [---] engagements

"@JamesEKrause @TOWiU2 You misspelled $ARWR. 😉"
X Link 2025-01-02T01:46Z [---] followers, [---] engagements

"@GeneInvesting @yaireinhorn @NatureBiotech Agree. Keep in mind they are all employees ( including. the CEO). Risk averse and shy to have a vision. The failures years later are considered as cost of doing business. I hope that many small caps with great projects can survive and make them pay dearly"
X Link 2025-01-02T04:22Z [---] followers, [--] engagements

"@meputzke20 $MREO Yes that would be the best approach for a BP. It would need a strategic approach to harvest setru bring it to market and expand its applications. Finish Alvelestat and expand it to #COPD. The dormant projects for high calibre mgt dev BP: SP $20 or MC $3.1B and its yours"
X Link 2025-01-02T05:40Z [---] followers, [---] engagements

"@RNAiAnalyst @GeneInvesting @BiomedicalRX Thats why I have invested in $ARWR (for first time almost [--] ago). My vision: To invest in a biotech company that evolves into a standalone pharmaceutical company. They made quite some mistakes and still make more. But maybe the levee has broken"
X Link 2025-01-02T08:34Z [---] followers, [---] engagements

"Yesterday in Melbourne. #RobbieWilliams gives a free concert"
X Link 2025-01-02T21:21Z [---] followers, [---] engagements

"@Biotech2k1 Your thoughts on $HIMS"
X Link 2025-01-03T21:02Z [---] followers, [---] engagements

"@bradloncar @TimOpler $ARWR and Vivo capital have created Virsina Pharmaceuticals a joint venture in China for the development of $ARWR drugs for greater China. The JV is majority owned by $ARWR. Seems the other way around here"
X Link 2025-01-08T05:08Z [---] followers, [----] engagements

"$LPTX There could be a paywall. In summary its a Buy but high risk (didnt we know that already) https://seekingalpha.com/article/4748800-undercovered-dozen-fannie-mae-civitas-resources-lifevantage-zenatech-plus https://seekingalpha.com/article/4748800-undercovered-dozen-fannie-mae-civitas-resources-lifevantage-zenatech-plus"
X Link 2025-01-12T11:24Z [---] followers, [---] engagements

"@SnupSnus https://jpmorgan.metameetings.net/events/healthcare25/sessions/58162-ultragenyx-pharmaceutical-inc/webcastgpu_only=true&kiosk=true https://jpmorgan.metameetings.net/events/healthcare25/sessions/58162-ultragenyx-pharmaceutical-inc/webcastgpu_only=true&kiosk=true"
X Link 2025-01-13T23:53Z [---] followers, [--] engagements

"@FeldtInvesting This also means that when the IA1 hits that they will disclose it. $MREO $RARE"
X Link 2025-01-14T02:17Z [---] followers, [---] engagements

"@Franca_ole @yusufhameed @PivotalReadout @SangamoTx Sometimes companies like HCW organise such meetings exclusively for their clients. $SGMO has no say in that. But they cannot disclose insider information"
X Link 2025-01-14T02:30Z [---] followers, [---] engagements

"@westieofwallst @FeldtInvesting $MREO $RARE Yes they were not informed. They were just expecting the data by year end if it had hit. My read even a small outlier could have hit the stats. It still could hit. But lets be honest the IA1 was a very high bar and both CEOs said that. P 0.01% more realistic"
X Link 2025-01-14T03:42Z [---] followers, [---] engagements

"@FeldtInvesting @westieofwallst $MREO $RARE Yes they made the their own conclusion and rightfully so. With all the hype on the IA1 they had to come up with some communication. They always can say that they move on to the next step because its one trial. $RARE communication is always a bit sensational"
X Link 2025-01-14T05:14Z [---] followers, [---] engagements

"@FeldtInvesting @westieofwallst $MREO communication much more down to earth. But then all the CEO bashers have their field"
X Link 2025-01-14T05:15Z [---] followers, [---] engagements

"@btcbabey $RARE $MREO He doesnt know anything. The data are secret. Being overly optimistic could be seen as misleading. As CEO you better be careful"
X Link 2025-01-14T07:05Z [---] followers, [---] engagements

"@alc2022 Sounds like $ARWR"
X Link 2025-01-19T11:26Z [---] followers, [---] engagements

"$MREO @StephanKlingel1 you need to chill out bro. The final decision have not been made yet by European Commission for final decision. @StephanKlingel1 you need to chill out bro. The final decision have not been made yet by European Commission for final decision"
X Link 2025-01-20T00:12Z [---] followers, [----] engagements

"@luigidt79 There seem to be some different interpretations. Therefore not sure. $MREO"
X Link 2025-01-20T00:29Z [---] followers, [---] engagements

"$ARWR first approval is coming. First of many. A total of [--] phase I / II / III assets in the clinic for @ArrowheadPharma This is impressive and many ambitious / lucrative targets https://t.co/4fhmYMt7KP $ARWR 1/3 https://t.co/hM75xzWrF7 A total of [--] phase I / II / III assets in the clinic for @ArrowheadPharma This is impressive and many ambitious / lucrative targets https://t.co/4fhmYMt7KP $ARWR 1/3 https://t.co/hM75xzWrF7"
X Link 2025-01-20T02:50Z [---] followers, [----] engagements

"$ARWR Actually bigger than $ALNY One day $ARWR will bring a drug to market. I still believe that this will happen in the end. What I'm not sure about yet what their path will look like after that similar to $ALNY or more like $IONS Let's do a poll: One day $ARWR will bring a drug to market. I still believe that this will happen in the end. What I'm not sure about yet what their path will look like after that similar to $ALNY or more like $IONS Let's do a poll:"
X Link 2025-01-23T11:34Z [---] followers, [----] engagements

"$HIMS Indeed a deep dive thread and it is great. A must read for everybody interested in $HIMS. Thanks. You can tell a lot about an investor by looking at their SWOT analysis Heres the Good vs. Bad on $HIMS (deep dive thread) https://t.co/po8LRHZcwV You can tell a lot about an investor by looking at their SWOT analysis Heres the Good vs. Bad on $HIMS (deep dive thread) https://t.co/po8LRHZcwV"
X Link 2025-01-30T00:40Z [---] followers, [---] engagements

"@AuruxXuruo @alc2022 At or around Feb [--]. $HIMS"
X Link 2025-01-31T11:12Z [---] followers, [---] engagements

"$HIMS thread Id assume Europe tariffs would be bullish for $HIMS Novo Nordisk $NVO has drug production sites in both China & Europe with big plans to invest even more in EU. If tariffs tighten things up for them while theyre trying ramp up production for semaglutide that could lead to Id assume Europe tariffs would be bullish for $HIMS Novo Nordisk $NVO has drug production sites in both China & Europe with big plans to invest even more in EU. If tariffs tighten things up for them while theyre trying ramp up production for semaglutide that could lead to"
X Link 2025-02-01T06:46Z [---] followers, [---] engagements

"@FeldtInvesting That's a good one $MREO $RARE. Thanks"
X Link 2025-02-03T23:38Z [---] followers, [---] engagements

"@BertrandBio $HIMS Copycat Its personalised. Big Pharma cant do that. Thats why $HIMS will stay"
X Link 2025-02-07T21:40Z [---] followers, [---] engagements

"@MikeDoesFinance $HIMS Think so too. The Hers part is totally underrated. Could be the dark horse"
X Link 2025-02-08T03:46Z [---] followers, [---] engagements

"@Varro_Analytics @JialiangLiang Follow the $ARWR discord channel. A more critical Arrowhead discord channel is Holdens Views"
X Link 2025-02-08T04:19Z [---] followers, [---] engagements

"@SeanDonlon1 @Yahoo $HIMS The attack will create a #StreisandEffect and millions more will become aware of the company and its products"
X Link 2025-02-09T04:10Z [---] followers, [---] engagements

"@don_sandor @alc2022 Read his deep dives on $HIMS and learn. Very ambitious but impossible"
X Link 2025-02-09T04:13Z [---] followers, [---] engagements

"$ARWR At Arrowhead we're dedicated to pursuing the development of therapies that have the potential to improve the lives of patients living with rare diseases. Learn more about them and our pipeline: https://t.co/g2Xi39Hnr9 #ForFCS #RareDiseaseMonth #RareDiseaseDay #FCSAwareness #HoFH https://t.co/WDqgRiQLCD At Arrowhead we're dedicated to pursuing the development of therapies that have the potential to improve the lives of patients living with rare diseases. Learn more about them and our pipeline: https://t.co/g2Xi39Hnr9 #ForFCS #RareDiseaseMonth #RareDiseaseDay #FCSAwareness #HoFH"
X Link 2025-02-19T06:12Z [---] followers, [---] engagements

"$ARWR (L) Me too. $ARWR: I bought $ARWR because I wanted more late stage companies with multiple drugs and multiple indications that could offer a lot of potential. I bought because the valuation was way below my estimates I bought because they have [--] later stage programs in cholesterol which $ARWR: I bought $ARWR because I wanted more late stage companies with multiple drugs and multiple indications that could offer a lot of potential. I bought because the valuation was way below my estimates I bought because they have [--] later stage programs in cholesterol which"
X Link 2025-02-23T20:01Z [---] followers, [---] engagements

"@BiomedicalRX Mine too $ARWR(L)"
X Link 2025-02-25T21:31Z [---] followers, [---] engagements

"@stats_feed [--] of [--] ( Hurghada Mauritius Kauai). Not bad"
X Link 2025-02-27T21:18Z [---] followers, [---] engagements

"Excellent article on biotech investment. Particularly interesting is that the author is using $BBIO as a case study incl. its #ATTR drug that was approved yesterday. Biotech Analysis: From [--] to [--] by @AduSubramanian https://open.substack.com/pub/adus/p/biotech-analysis-from-0-to-1r=cwfd7&utm_campaign=post&utm_medium=web&showWelcomeOnShare=false https://open.substack.com/pub/adus/p/biotech-analysis-from-0-to-1r=cwfd7&utm_campaign=post&utm_medium=web&showWelcomeOnShare=false"
X Link 2025-03-21T08:34Z [---] followers, [---] engagements

"$HIMS Quite open about restarting the CTO hiring process to find the right person with the right fit. Speaks well about the CEO"
X Link 2025-03-25T04:00Z [---] followers, [---] engagements

"@DeepValueReport $GOOG"
X Link 2025-03-30T02:11Z [---] followers, [--] engagements

"An area which $HIMS can get into via personalisation ( not necessarily Ozempic if FDA restrictions become permanent) https://t.co/22ZEcHuWaZ https://t.co/22ZEcHuWaZ"
X Link 2025-03-30T21:30Z [---] followers, [---] engagements

"@topsecretstocks Have you ever reviewed $WISE.LON $NU is working on their tech platform. My own experience is with the product and that is excellent"
X Link 2025-04-18T01:03Z [---] followers, [---] engagements

"Told you so $HIMS 🧵 Hims: The Healthcare Rocket Ready to Burn the Shorts in [----] $HIMS just posted one of the most explosive Q4s in the healthcare space. +95% YoY revenue $1.5B full-year revenue +322% YoY free cash flow Lets break it down 👇 🧵 Hims: The Healthcare Rocket Ready to Burn the Shorts in [----] $HIMS just posted one of the most explosive Q4s in the healthcare space. +95% YoY revenue $1.5B full-year revenue +322% YoY free cash flow Lets break it down 👇"
X Link 2025-04-18T20:56Z [---] followers, [---] engagements

"@Mayhem4Markets @Orangeman1992 They havent included the current #biotech #xbi bear market [--] years and counting decline 75%😉 real recovery: never"
X Link 2025-04-21T01:13Z [---] followers, [--] engagements

"$ARWR Good on you. Market: Time to wake up. $ARWR very exciting program. No way big pharma will not be watching these results. Valuation here remains irresponsible imho. #obesity #diabetes https://t.co/UJ4USH1tot $ARWR very exciting program. No way big pharma will not be watching these results. Valuation here remains irresponsible imho. #obesity #diabetes https://t.co/UJ4USH1tot"
X Link 2025-04-23T01:58Z [---] followers, [---] engagements

"Thats what I think. The $NVAX vaccine is not available in Australia. No explanation. @DrMakaryFDA Can you please ask Novavax if they are delaying submission to TGA for JN1 until FDA approval because Australians have not had access to XBB or JN1 nonmRNA vaccine option and it's NOT OK when there is an APA. We deserve to know exactly what the plan is. @DrMakaryFDA Can you please ask Novavax if they are delaying submission to TGA for JN1 until FDA approval because Australians have not had access to XBB or JN1 nonmRNA vaccine option and it's NOT OK when there is an APA. We deserve to know exactly"
X Link 2025-04-26T22:58Z [---] followers, [---] engagements

"A great development and example for Australia. Today's @abcnews column about the healthcare revolution taking place in the Melbourne suburb of Kew. https://t.co/Yqo12WZS0k Today's @abcnews column about the healthcare revolution taking place in the Melbourne suburb of Kew. https://t.co/Yqo12WZS0k"
X Link 2025-04-27T22:12Z [---] followers, [---] engagements

"$ARWR (L) Nobody understands that. But here we are. Just started digging into $ARWR so take this as a newbie's rambling. But it looks crazy undervalued. Theyve got a near-approval RNAi drug (PDUFA in Nov) and early-stage obesity programs that could be long-acting. Yet its trading close to cash Just started digging into $ARWR so take this as a newbie's rambling. But it looks crazy undervalued. Theyve got a near-approval RNAi drug (PDUFA in Nov) and early-stage obesity programs that could be long-acting. Yet its trading close to cash"
X Link 2025-04-30T00:47Z [---] followers, [---] engagements

"Great article. Sounds like desperation on the side of $CRSP. #RNAi $PRME $BEAM $EDIT $ARWR What if a dual-targeting dimer drug (PCSK9 + AOC3) will enter the clinic in 2025potential game-changer for LDL and triglyceride lowering. Would anyone really want gene therapy in CVD I think I'm going mad.or ' #CRISPR Therapeutics Goes RNAi in Major Embarrassment to Field' (blog): https://t.co/Gx3TJtsIiB $CRSP #RNAi $PRME $BEAM $EDIT $ALNY I think I'm going mad.or ' #CRISPR Therapeutics Goes RNAi in Major Embarrassment to Field' (blog): https://t.co/Gx3TJtsIiB $CRSP #RNAi $PRME $BEAM $EDIT $ALNY"
X Link 2025-05-23T01:56Z [---] followers, [----] engagements

"Want to learn about Prime- and Base editing issues Read this article. $BEAM $PRME @davidrliu Paging @davidrliu. #BeamTherapeutics and #PrimeMedicine Need to Unite (blog): https://t.co/hUO8kYiDYM #CRISPR $BEAM $PRME Paging @davidrliu. #BeamTherapeutics and #PrimeMedicine Need to Unite (blog): https://t.co/hUO8kYiDYM #CRISPR $BEAM $PRME"
X Link 2025-05-25T09:39Z [---] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing